-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
-
Summary
-
CNBX Pharmaceuticals Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from Q4 2011 to Q4 2024.
- CNBX Pharmaceuticals Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending November 30, 2024 was $30K, a 20% increase year-over-year.
- CNBX Pharmaceuticals Inc. annual Net Cash Provided by (Used in) Financing Activities for 2024 was $27.5K, a 72.5% decline from 2023.
- CNBX Pharmaceuticals Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $100K, a 74.4% decline from 2022.
- CNBX Pharmaceuticals Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $390K, a 84.1% decline from 2021.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)